156 related articles for article (PubMed ID: 27399092)
1. Genetic variants of the CYP1B1 gene as predictors of biochemical recurrence after radical prostatectomy in localized prostate cancer patients.
Gu CY; Qin XJ; Qu YY; Zhu Y; Wan FN; Zhang GM; Sun LJ; Zhu Y; Ye DW
Medicine (Baltimore); 2016 Jul; 95(27):e4066. PubMed ID: 27399092
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants in the Hippo pathway predict biochemical recurrence after radical prostatectomy for localized prostate cancer.
Huang CY; Huang SP; Lin VC; Yu CC; Chang TY; Juang SH; Bao BY
Sci Rep; 2015 Feb; 5():8556. PubMed ID: 25707771
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in microRNAs and microRNA target sites predict biochemical recurrence after radical prostatectomy in localized prostate cancer.
Huang SP; Lévesque E; Guillemette C; Yu CC; Huang CY; Lin VC; Chung IC; Chen LC; Laverdière I; Lacombe L; Fradet Y; Chang TY; Lee HZ; Juang SH; Bao BY
Int J Cancer; 2014 Dec; 135(11):2661-7. PubMed ID: 24740842
[TBL] [Abstract][Full Text] [Related]
4. Genetic interaction analysis of TCF7L2 for biochemical recurrence after radical prostatectomy in localized prostate cancer.
Chen CS; Huang CY; Huang SP; Lin VC; Yu CC; Chang TY; Bao BY
Int J Med Sci; 2015; 12(3):243-7. PubMed ID: 25678841
[TBL] [Abstract][Full Text] [Related]
5. Effect of genetic variants in cell adhesion pathways on the biochemical recurrence in prostate cancer patients with radical prostatectomy.
Yu CC; Chen LC; Lin VC; Huang CY; Cheng WC; Hsieh AR; Chang TY; Lu TL; Lee CH; Huang SP; Bao BY
Cancer Med; 2019 Jun; 8(6):2777-2783. PubMed ID: 30993852
[TBL] [Abstract][Full Text] [Related]
6. A single nucleotide polymorphism in ADIPOQ predicts biochemical recurrence after radical prostatectomy in localized prostate cancer.
Gu C; Qu Y; Zhang G; Sun L; Zhu Y; Ye D
Oncotarget; 2015 Oct; 6(31):32205-11. PubMed ID: 26320190
[TBL] [Abstract][Full Text] [Related]
7. Cancer Stem Cell Gene Variants Predict Disease Recurrence in Patients Treated with Radical Prostatectomy for Prostate Cancer.
Lin VC; Huang SP; Huang CY; Yu CC; Yin HL; Huang TY; Lee CH; Lu TL; Bao BY
Int J Med Sci; 2017; 14(12):1301-1306. PubMed ID: 29104488
[No Abstract] [Full Text] [Related]
8. Glutathione-S-transferase (GST) polymorphisms are associated with relapse after radical prostatectomy.
Cotignola J; Leonardi DB; Shahabi A; Acuña AD; Stern MC; Navone N; Scorticati C; De Siervi A; Mazza O; Vazquez E
Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):28-34. PubMed ID: 23146971
[TBL] [Abstract][Full Text] [Related]
9. The UGT1 locus is a determinant of prostate cancer recurrence after prostatectomy.
Laverdière I; Flageole C; Audet-Walsh É; Caron P; Fradet Y; Lacombe L; Lévesque É; Guillemette C
Endocr Relat Cancer; 2015 Feb; 22(1):77-85. PubMed ID: 25452636
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy.
Huang SP; Huang LC; Ting WC; Chen LM; Chang TY; Lu TL; Lan YH; Liu CC; Yang WH; Lee HZ; Hsieh CJ; Bao BY
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3068-74. PubMed ID: 19900942
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide detection of allelic genetic variation to predict biochemical recurrence after radical prostatectomy among prostate cancer patients using an exome SNP chip.
Oh JJ; Park S; Lee SE; Hong SK; Lee S; Lee HM; Lee JK; Ho JN; Yoon S; Byun SS
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1493-501. PubMed ID: 25764380
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence.
Gu C; Li Q; Zhu Y; Qu Y; Zhang G; Wang M; Yang Y; Wang J; Jin L; Wei Q; Ye D
Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):310-6. PubMed ID: 26238235
[TBL] [Abstract][Full Text] [Related]
13. Genetic predisposition to early recurrence in clinically localized prostate cancer.
Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
[TBL] [Abstract][Full Text] [Related]
14. The EGFR polymorphism rs884419 is associated with freedom from recurrence in patients with resected prostate cancer.
Perez CA; Chen H; Shyr Y; Courtney R; Zheng W; Cai Q; Hwang M; Jaboin J; Schleicher S; Moretti L; Wills M; Smith JA; Lu B
J Urol; 2010 May; 183(5):2062-9. PubMed ID: 20303520
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Relevance of Methylenetetrahydrofolate Reductase Polymorphisms for Prostate Cancer.
Lin VC; Lu TL; Yin HL; Yang SF; Lee YC; Liu CC; Huang CY; Yu CC; Chang TY; Huang SP; Bao BY
Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27916838
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy.
Li T; Gui Y; Yuan T; Liao G; Bian C; Jiang Q; Huang S; Liu B; Wu D
BJU Int; 2012 Dec; 110(11 Pt C):E1125-30. PubMed ID: 22672360
[TBL] [Abstract][Full Text] [Related]
17. SRD5A polymorphisms and biochemical failure after radical prostatectomy.
Audet-Walsh E; Bellemare J; Nadeau G; Lacombe L; Fradet Y; Fradet V; Huang SP; Bao BY; Douville P; Girard H; Guillemette C; Lévesque E
Eur Urol; 2011 Dec; 60(6):1226-34. PubMed ID: 21715084
[TBL] [Abstract][Full Text] [Related]
18. Steroidogenic germline polymorphism predictors of prostate cancer progression in the estradiol pathway.
Lévesque E; Laverdière I; Audet-Walsh E; Caron P; Rouleau M; Fradet Y; Lacombe L; Guillemette C
Clin Cancer Res; 2014 Jun; 20(11):2971-83. PubMed ID: 24682418
[TBL] [Abstract][Full Text] [Related]
19. Hypertriglyceridemia is a potential preoperative predictor for biochemical recurrence after radical prostatectomy.
Kang M; Jeong CW; Ku JH; Kwak C; Kim HH
PLoS One; 2015; 10(3):e0122438. PubMed ID: 25803284
[TBL] [Abstract][Full Text] [Related]
20. Influence of cytokine gene polymorphisms on prostate-specific antigen recurrence in prostate cancer after radical prostatectomy.
Lin HC; Liu CC; Kang WY; Yu CC; Wu TT; Wang JS; Wu WJ; Huang CH; Wu MT; Huang SP
Urol Int; 2009; 83(4):463-70. PubMed ID: 19996656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]